Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 2, 2014, Pages 322-332

  Zhang, Hanwen ^a   Huang, Ruimin ^a   Pillarsetty, NagaVaraKishore ^a   Thorek, Daniel L J ^a   Vaidyanathan, Ganesan ^b   Serganova, Inna ^a   Blasberg, Ronald G ^a   Lewis, Jason S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HNETreporter gene; PET imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE F 18; (3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 124; (3 IODOBENZYL)GUANIDINE I 131; META FLUOROBENZYLGUANIDINE F 18; NORADRENALIN TRANSPORTER; PARA FLUOROBENZYLGUANIDINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 3 FLUOROBENZYLGUANIDINE; 3-FLUOROBENZYLGUANIDINE; 4 FLUOROBENZYLGUANIDINE; 4-FLUOROBENZYLGUANIDINE; FLUOROBENZENE; GUANIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CULTURE MEDIUM; FLUORINATION; GLIOMA CELL; HALOGENATION; IN VITRO STUDY; LIPOPHILICITY; MALE; NONHUMAN; PLASMA PROTEIN BINDING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOCHEMISTRY; RAT; REPORTER GENE; SYNTHESIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WILD TYPE; XENOGRAFT; ANIMAL; DRUG SCREENING; GLIOMA; HUMAN; METABOLISM; MOUSE; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FLUOROBENZENES; GLIOMA; GUANIDINES; HUMANS; MICE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897096390     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2558-9     Document Type: Article

References (26)

1. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350-4.
2. Axelrod J, Kopin IJ. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res 1969;31:21-32.
3. Anton M, Wagner B, Haubner R, Bodenstein C, Essien BE, Bönisch H, et al. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med 2004;6:119-26.
4. Moroz MA, Serganova I, Zanzonico P, Ageyeva L, Beresten T, Dyomina E, et al. Imaging hNET reporter gene expression with 124I-MIBG. J Nucl Med 2007;48:827-36.
5. Grünwald F, Ezziddin S. 131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors. Semin Nucl Med 2010;40:153-63.
6. Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261:243-57.
7. Pryma D, Divgi C. Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors. Nucl Med Biol 2008;35:5.
8. Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR. 123I-meta- iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 2010;95:2596-606.
9. Fonte JS, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, et al. False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer 2012;19: 83-93.
10. Vaidyanathan G. Meta-iodobenzylguanidine and analogues: chemistry and biology. Q J Nucl Med Mol Imaging 2008;52:351-68.
11. Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, et al. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET. Med Phys 2010;37:4861-7.
12. Watanabe S, Hanaoka H, Liang JX, Iida Y, Endo K, Ishioka NS. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta- bromobenzylguanidine. J Nucl Med 2010;51:1472-9.
13. Garg PK, Garg S, Zalutsky MR. Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine. Nucl Med Biol 1994;21:97-103.
14. Berry CR, Garg PK, Zalutsky MR, Coleman RE, DeGrado TR. Uptake and retention kinetics of para-fluorine-18-fluoro-benzylguanidine in isolated rat heart. J Nucl Med 1996;37:2011-6.
15. Berry CR, DeGrado TR, Nutter F, Garg PK, Breitschwerdt EB, Spaulding K, et al. Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine. Vet Radiol Ultrasound 2002;43:183-6.
16. Vaidyanathan G, Affleck DJ, Zalutsky MR. (4-[18F]fluoro-3-iodobenzyl) guanidine, a potential MIBG analogue for positron emission tomography. J Med Chem 1994;37:3655-62.
17. Vaidyanathan G, Affleck DJ, Zalutsky MR. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. J Nucl Med 1995;36:644-50.
18. Lee BC, Paik JY, Chi DY, Lee KH, Choe YS. Potential and practical adrenomedullary PET radiopharmaceuticals as an alternative to m-iodobenzylguanidine: m-(omega-[18F]fluoroalkyl)benzylguanidines. Bioconjug Chem 2004;15:104-11.
19. Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, et al. Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging 2013;40:1077-83.
20. Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, et al. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 2011;4:435-43.
21. *I]MIBG and [211At]MABG. J Labelled Comp Radiopharm 2007;50:177-82.
22. Ohara K, Vasseur JJ, Smietana M. NIS-promoted guanylation of amines. Tetrahedron Lett 2009;50:1463-5.
23. Zhang H, Huang R, Lewis JS, Blasberg RG. Imaging human norepinephrine transporter (hNET) expressing reporter cells and tumors with 4-18F-fluorobenzylguanidine. J Nucl Med 2012;53:1584.
24. Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med 2007;37:286-302.
25. Travin MI. Cardiac neuronal imaging at the edge of clinical application. Cardiol Clin 2009;27:311-27.
26. Vaidyanathan G, Zalutsky MR. No-carrier-added meta-[123I]iodo- benzylguanidine: synthesis and preliminary evaluation. Nucl Med Biol 1995;22:61-4.